Perfecting The European Medtech Accelerator And Funding Vehicle
Sofinnova Partners’ early-stage, "stay lean" approach to funding and incubating innovative medtech is unique in Europe, believes partner Anne Osdoit. She is seeking more investments for the company’s major MD Start III fund, while trying not to focus too much on thoughts of the next iteration.
You may also be interested in...
Focus On Switzerland – Part 3: Robotics means different things to different surgeons, according to Swiss innovator Distalmotion, whose surgical robot combines with laparoscopy to leave the surgeon fully in control in the OR.
The pressures on global medtechs to focus more on sustainability are internal as well as external. Scope 3 adds yet another layer of compliance. Johnson & Johnson’s EMEA VP for Surgical Vision Erin McEachren explains to In Vivo how her organization meets these challenges while simultaneously addressing EU Medical Device Regulation requirements and ensuring patient safety standards.
As the health care sector moves from linear to circular, medtechs, providers and patients all have roles to play in ensuring that current strategies, practices and behaviors contribute to guarantee a sustainable future. Part one of a short series on this theme looks as best practice for providers.